Know Cancer

or
forgot password

Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast


N/A
18 Years
N/A
Not Enrolling
Both
Head and Neck Cancer, Head and Neck Cancers

Thank you

Trial Information

Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast


Inclusion Criteria:

Patients with newly diagnosed squamous cell carcinomas of the H&N with
primary tumor sites that are accessible to direct contrast injections

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

To determined the ability of magnetic resonance lymphangiography using conventional gadolinium injected directly into the tumor site and PET scan in detecting microscopic nodal metastasis in patients with newly diagnosed H&N cancers

Outcome Time Frame:

unknown

Safety Issue:

No

Principal Investigator

Quynh-Thu Le

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

ENT0010

NCT ID:

NCT00230295

Start Date:

February 2003

Completion Date:

November 2007

Related Keywords:

  • Head and Neck Cancer
  • Head and Neck Cancers
  • Head and Neck Neoplasms

Name

Location

Stanford University School of MedicineStanford, California  94305-5317